Form D · Biotechnology
CoRegen, Inc.
Houston, TX · CIK 0002012886
Offering snapshot reported Feb 26, 2026 · SEC filing
- Reported sold
- $13.5M Offering amount: $13.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2026 | Initial | $13,500,000 | No comparison | 1 | SEC filing |
| May 22, 2025 | Initial | $62,640,000 | No comparison | 8 | SEC filing |
| Feb 28, 2025 | Initial | $20,750,000 | No comparison | 7 | SEC filing |
| Feb 28, 2025 | Initial | $10,000,002 | No comparison | 1 | SEC filing |
| Mar 8, 2024 | Initial | $12,870,000 | No comparison | 31 | SEC filing |
| Feb 22, 2024 | Initial | $14,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $540K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-574816
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Stonehaven, LLC | 118913 | Marc Christopher Rucinski · CRD 4543011 |
Source: Form D, filed Feb 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edward J. Benz, Jr. | Director |
| David M. Cornell, Ii | Director |
| Clifford C. Dasco, M.D. | Director, Executive |
| Lee Fleisher | Director |
| Lee Fleisher, M.D. | Director |
| Peter Gelinas | Executive |
| Steve Gorlin | Director, Executive |
| Sonal Gupta | Executive |
| William Haseltine, Ph D. | Director |
| David Lonard, Ph D | Executive |
| Sonja Nelson | Executive |
| Bert W. O'malley | Director |
| Bert W. O'malley, M.D. | Director |
| Jonathan W. Simons | Director |
| John Thomas, Jr. | Executive |
| Shawn C. Tomasello | Director, Executive |
| Suneet Varma | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
801 Travis Street Suite 2101
Houston, TX, 77002
Houston, TX, 77002